Adaptive Biotechnologies Corpor

Historical 13F Holders

Symbol
ADPT
CUSIP
00650F109
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 00650F109 since 12/18/2024, largest first.

Filer % of Class Filed
Viking Global Investors LP 13G/A
18.8% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 7.9% 1/21/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Nikko Asset Management Americas, Inc. 13G/A 4.6% 2/13/2025
Event 12/31/2024
Sumitomo Mitsui Trust Group, Inc. 13G/A
4.6% 2/4/2025
Event 12/31/2024
Integrated Core Strategies (US) LLC 13G/A
4.3% 1/27/2025
Event 12/31/2024
Rubric Capital Management LP 13G/A
4.1% 7/9/2025
Event 6/30/2025
ARK Investment Management LLC 13G/A
2.9% 6/6/2025
Event 5/31/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 245 86.2 M $2.49B
2026 Q2 305 156 M $3.34B
2026 Q1 301 152 M $2.11B
2025 Q4 285 150 M $2.44B
2025 Q3 271 145 M $2.18B
2025 Q2 243 148 M $1.73B
2025 Q1 226 153 M $1.14B
2024 Q4 208 143 M $859M
2024 Q3 189 143 M $732M
2024 Q2 179 149 M $539M
2024 Q1 192 143 M $457M
2023 Q4 203 144 M $704M
2023 Q3 193 141 M $769M
2023 Q2 212 137 M $921M
2023 Q1 228 134 M $1.18B
2022 Q4 227 133 M $1.02B
2022 Q3 229 131 M $931M
2022 Q2 214 134 M $1.08B
2022 Q1 224 126 M $1.74B
2021 Q4 216 123 M $3.46B
2021 Q3 220 118 M $4.00B
2021 Q2 233 117 M $4.80B
2021 Q1 251 114 M $4.58B
2020 Q4 255 114 M $6.75B
2020 Q3 210 111 M $5.41B
2020 Q2 200 101 M $4.89B
2020 Q1 149 96.9 M $2.69B
2019 Q4 134 86.3 M $2.58B
2019 Q3 117 81.1 M $2.50B
2019 Q2 113 78.2 M $3.74B
2019 Q1 1 104 k $4.25M
2016 Q3 2 248 $10.7k
2016 Q2 1 13.0 $672
2016 Q1 1 9.00 $500